|
Issue |
Title |
|
Vol 2, No 2 (2016) |
Meta-analysis on the PARP-inhibitor olaparib reveals therapeutic efficacy in ovarian cancer independent of BRCA1/2 mutation status |
Abstract
PDF
|
Ines Vasconcelos, Oscar Gaspar |
|
Vol 3, No 3 (2017) |
Identification and verification of a pathogenic MLH1 mutation c.1145dupA in a Lynch syndrome family |
Abstract
PDF
|
Huang Feifei, Tao Xiang, Jiang Wei, Chen Jun, Feng Weiwei |
|
Vol 3, No 6 (2017) |
A comparison study of droplet digital PCR and qPCR for EGFR T790M detection in plasma of NSCLC patients |
Abstract
PDF
|
Chien Wen Tay, Che Zairieha, Raja Iswara, Saira Yousoof, Yoke Kqueen Cheah, Pathmanathan Rajadurai |
|
Vol 3, No 6 (2017) |
Inherited mutations in BRCA1 and BRCA2 in an unselected multi-ethnic cohort of Asian breast cancer patients and healthy controls from Malaysia |
Abstract
PDF
|
Eldarina Wijaya, Wei Xiong Wen, Kah Nyin Lai, Jamie Allen, Craig Luccarini, Joanna Lim, Min Min Tan, Shivaani Mariapun, Cheng Har Yip, Nur Aishah Mohd Taib, Alison Dunning, Douglas Easton, Soo Hwang Teo |
|
Vol 3, No 6 (2017) |
Protocol for the mainstreaming genetic counselling for genetic testing of BRCA1 and BRCA2 in ovarian cancer patients in Malaysia (MaGiC study) |
Abstract
PDF
|
Nor Syuhada Ahmad Bashah, Yin Leng Woo, Joanna Lim, Meow Keong Thong, Soo Hwang Teo, MaGiC Investigators, Sook Yee Yoon |
|
Vol 3, No 4 (2017) |
Successful afatinib treatment through nasogastric tube in a ventilated patient with non-small cell lung cancer |
Abstract
PDF
|
Takahiro Karasuno, Nobuko Nishiura, Hiroyuki Takamori, Ken Kodama |
|
Vol 4, No 6 (2018) |
Dysregulated TCA Cycle Pathway in Endometrial Cancer |
Abstract
PDF
|
Yuexin Liu |
|
1 - 7 of 7 Items |
|